Public Health – Page 12

Australia Report: Seven Major Challenges of Safe and Reliable Medical Artificial Intelligence in Legislation and Regulation

By MedXY 08/17/2025

This report outlines the challenges and recommendations for implementing AI in healthcare while ensuring safety and responsibility in Australia.

Family Medicine & Nutrition Medical News news Public Health Specialties

Evaluating Salt Warning Labels to Reduce High Salt Consumption in UK Out-of-Home Food Sector: Evidence from Online and Real-world Randomised Controlled Trials

By MedXY 08/15/2025

UK trials show salt warning labels on packaged foods and menus effectively increase awareness and discourage high salt intake, offering a promising policy to combat cardiovascular risk associated with excessive salt consumption.

Infectious Diseases news Public Health Specialties

Long-term Safety and Efficacy of Rabies Monoclonal Antibody and Vaccine for Post-Exposure Prophylaxis: Insights from a Phase 4 Trial in India

By MedXY 08/15/2025

A phase 4 randomized trial demonstrates that combining rabies monoclonal antibody with vaccine in category 3 exposures is safe, immunogenic, and effective in preventing rabies up to one year post-exposure.

news Public Health Specialties

Workplace Violence in Urban and Rural Hospitals: A Growing Threat with High Costs

By MedXY 08/14/2025

Workplace violence in American hospitals causes significant trauma, financial costs, and operational challenges, affecting both urban and rural hospitals equally, despite differences in available resources. Prevention and trauma-informed response are critical.

AI news Public Health Specialties

When an AI ‘Suggestion’ Became Poison: A Case of Bromide Toxicity After ChatGPT Advised Replacing Table Salt

By MedXY 08/10/2025

A 60-year-old man developed bromide toxicity after replacing dietary NaCl with NaBr based on ChatGPT guidance; the case highlights laboratory interference, diagnostic pitfalls, clinical management, and risks of decontextualized AI health advice.

Medical News news Public Health Specialties

Your Home Directly Impacts Your Health: Insights from The Lancet

By MedXY 08/06/2025

Housing quality critically influences health outcomes, yet global public health often overlooks it. Urgent action and investment are needed to ensure adequate housing as a fundamental human right.

Family Medicine & Nutrition Medical News news Public Health Specialties

Comparing the Effectiveness of Influenza Vaccines: Subunit Vaccine vs. Split-Virion Vaccine

By MedXY 08/04/2025

A prospective study shows split-virion vaccines offer significantly higher protection against influenza than subunit vaccines in adults 50 and older, highlighting the importance of vaccine selection.

Clinical Updates Family Medicine & Nutrition news Public Health Specialties

Seasonal Malaria Chemoprevention in Uganda: Efficacy of SPAQ and Dihydroartemisinin-Piperaquine in the Era of Drug Resistance

By MedXY 08/03/2025

A large cluster-randomised trial in Uganda demonstrates that both SPAQ and dihydroartemisinin-piperaquine are highly effective and safe for seasonal malaria chemoprevention in children, with no evidence of resistance selection.

Clinical Updates news Public Health Respiratory Specialties

Targeted Pneumococcal Vaccination in New Older Adult Care Home Residents: Evidence from National Surveillance in England

By MedXY 08/03/2025

Vaccinating new older adult care home residents with PCV20 or PPV23 could prevent substantially more invasive pneumococcal disease cases and deaths per dose than standard age-based vaccination, supporting policy revision.

Clinical Updates Infectious Diseases Public Health Specialties

Real-World Safety and Effectiveness of MVA-BN Vaccination Against Mpox: Evidence from German, Systematic Review, and Immunogenicity Cohorts

By MedXY 08/03/2025

MVA-BN vaccination is safe and effective against mpox in at-risk populations, but reduced protection is noted in people living with HIV. Dose strategies and patient immunological status may affect outcomes.

Clinical Updates news Public Health Specialties

Efficacy of the OurFutures Vaping eHealth Intervention in Preventing Adolescent E-Cigarette Use: Insights from a Landmark Australian Cluster RCT

By MedXY 08/02/2025

A large Australian cluster RCT demonstrates that a school-based eHealth intervention, OurFutures Vaping, significantly reduces adolescent e-cigarette use by 65% compared to usual health education over 12 months.

Medical News news Public Health Specialties

Understanding Legionnaires’ Disease: A Public Health Concern

By MedXY 08/02/2025

Legionnaires’ disease is a severe lung infection caused by bacteria in contaminated water systems. Recent cases in NYC highlight the importance of prevention and management.

Medical News news Public Health Specialties

Declining Vaccination Rates Among US Kindergarteners: A Growing Public Health Concern

By MedXY 08/02/2025

Vaccination rates for US kindergarteners have declined for the third consecutive year, raising public health concerns. Experts attribute this trend to increased vaccine hesitancy and misinformation.

Clinical Updates Infectious Diseases news Public Health Specialties

Corynebacterium diphtheriae Outbreak among Migrants in Europe: Clinical, Epidemiologic, and Microbiologic Insights

By MedXY 08/01/2025

A multicountry outbreak of diphtheria among migrants in Europe raised concerns about cutaneous and respiratory disease, cross-border spread, and emerging antibiotic resistance. Genomic analysis revealed multiclonal transmission and resistance challenges for standard therapies.

Cardiology Clinical Updates news Public Health Specialties

High-Dose and Adjuvanted Flu Vaccines Offer Equivalent Protection for Older US Adults

By MedXY 07/31/2025

A large US study finds adjuvanted and high-dose quadrivalent influenza vaccines provide comparable protection against lab-confirmed flu in seniors, supporting current immunization guidelines.

HIV/AIDS Medical News news Public Health Specialties

FDA Approves Lenacapavir: A Twice-Yearly Injectable PrEP Transforming HIV Prevention

By MedXY 07/31/2025

Lenacapavir (Yeztugo) becomes the first FDA-approved, twice-yearly injectable PrEP, offering robust long-acting HIV prevention and addressing key adherence barriers.

Clinical Updates Infectious Diseases news Public Health Specialties

West Nile Virus: Clinical Burden, Diagnostic Challenges, and Prevention in the U.S.

By MedXY 07/31/2025

West Nile virus is the leading mosquito-borne disease in the U.S., causing significant neuroinvasive morbidity and mortality, especially in older and immunocompromised individuals. With no approved treatments or vaccines, prevention and surveillance remain paramount.

Family Medicine & Nutrition news Pediatrics Public Health Specialties

Sweetener Consumption and Genetic Predisposition: New Insights into Early Puberty Risk in Children

By Dr.Paul 07/31/2025

Sweetener intake, especially aspartame and sucralose, is linked to increased risk of early puberty in genetically predisposed children, with notable sex-specific differences

Clinical Updates Medical News Pediatrics Public Health Specialties

Aluminum-Adjuvanted Vaccines in Early Childhood and Risk of Chronic Autoimmune, Allergic, and Neurodevelopmental Disorders: Insights from a Danish Nationwide Cohort Study

By MedXY 07/31/2025

A comprehensive Danish cohort study finds no evidence linking early childhood aluminum-adsorbed vaccines to increased risks of autoimmune, allergic, or neurodevelopmental disorders, supporting vaccine safety.

Medical News news Public Health Specialties

Understanding Adult Responses to Cannabis Health Warnings in US Recreational States: Insights from the EPPM Model

By MedXY 07/30/2025

A recent study reveals that most adults in US recreational states respond maladaptively to cannabis health warnings, highlighting challenges and opportunities for improved public health messaging.